FY2025 · ended Dec 31, 2025 · Revenue $24.95B, +1.5% YoY · Filed Feb 3, 2026
3M Company (MMM) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $24.9 billion and net income of $3.2 billion. Free cash flow was $1.4 billion. As of Sep 30, 2026 it held $4.8 billion in cash and investments and $15.6 billion in total debt.
Revenue (TTM)
$25.25B
+1.7% vs year-ago TTM
Net income (TTM)
$3.54B
+4.0% vs year-ago TTM
Operating cash flow (TTM)
$3.63B
+42.8% vs year-ago TTM
Free cash flow (TTM)
$2.68B
+68.6% vs year-ago TTM
EPS (TTM)
$6.68
+6.7% vs year-ago TTM
Dividend per share (TTM)
$3.07
+6.2% vs year-ago TTM
Shares outstanding
526.70M
-3.0% vs prior year
Net cash
$-10.76B
as of Sep 30, 2026
Operating margin
18.8%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MMM (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- St Paul, MN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 66740
- Former names
- MINNESOTA MINING & MANUFACTURING CO (until Feb 6, 2002)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
- West Pharmaceutical Services Inc WST
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $24.9B | $24.6B | $24.6B | $26.2B | $35.4B |
| Operating income | $4.6B | $4.8B | -$10.7B | $4.4B | $7.4B |
| Net income | $3.2B | $4.2B | -$7.0B | $5.8B | $5.9B |
| Diluted EPS | $6.00 | $7.55 | -$12.63 | $10.18 | $10.12 |
| Operating cash flow | $2.3B | $1.8B | $6.7B | $5.6B | $7.5B |
| Free cash flow | $1.4B | $638.0M | $5.1B | $3.8B | $5.9B |
| Total assets | $37.7B | $39.9B | $50.6B | $46.5B | $47.1B |
| Total liabilities | $33.0B | $36.0B | $45.7B | $31.7B | $32.0B |
| Stockholders' equity | $4.7B | $3.8B | $4.8B | $14.7B | $15.0B |
| Cash and investments | $5.2B | $5.6B | $5.9B | — | — |
| Total debt | $13.1B | $13.7B | $15.1B | $16.9B | $18.3B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Other events
|
Nov 4, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Oct 20, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 20, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 19, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Other events
|
Sep 10, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Aug 19, 2026 | Aug 17, 2026 |
All 1001 3M Company SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.